Search research articles
Contact Us
Filters
Showing results (171-180 of 288) with videos related to
Page
of 29
Sort By:
Reviews in Cardiovascular Medicine
|
August 14, 2024
Prevalence and Prognostic Significance of Malnutrition in Patients with Type B Aortic Dissection Undergoing Endovascular Repair
Ting Zhou, Songyuan Luo, Wenhui Lin, et al.
Clinical Interventions in Aging
|
May 7, 2024
Assess the Outcomes of Transcatheter Aortic Valve Replacement in Bicuspid Valve with Mixed Disease versus Predominant Aortic Stenosis
Changjin Wang, Xiaolu Hu, Songyuan Luo, et al.
Asian Journal of Urology
|
February 11, 2021
Sustainable functional urethral reconstruction: Maximizing early continence recovery in robotic-assisted radical prostatectomy
Zepeng Jia, Yifan Chang, Yan Wang, et al.
Journal of Cellular Physiology
|
November 19, 2013
miR-663 induces castration-resistant prostate cancer transformation and predicts clinical recurrence
Li Jiao, Zhen Deng, Chuanliang Xu, et al.
The Journal of Urology
|
October 19, 2010
Testosterone and androgen receptor in human nephrolithiasis
Jin-Yi Li, Tie Zhou, XiaoFeng Gao, et al.
Oncotarget
|
March 5, 2016
Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation
Biming He, Rui Chen, Xu Gao, et al.
BMC Cancer
|
June 21, 2019
Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms
Shuxiong Zeng, Anwei Liu, Lihe Dai, et al.
BJU International
|
May 27, 2018
Renal function changes after percutaneous nephrolithotomy in patients with renal calculi with a solitary kidney compared to bilateral kidneys
Xiaolei Shi, Yonghan Peng, Ling Li, et al.
BMC Cancer
|
March 22, 2013
Safety and efficacy of everolimus in Chinese patients with metastatic renal cell carcinoma resistant to vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: an open-label phase 1b study
Jun Guo, Yiran Huang, Xu Zhang, et al.
Molecular Cancer Therapeutics
|
December 29, 2012
miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR
Chuanliang Xu, Qinsong Zeng, Weidong Xu, et al.
Page
of 29
Search research articles
Search
Showing results (171-180 of 288) with videos related to
Sort By:
Page
of 29
Reviews in Cardiovascular Medicine
|
August 14, 2024
Prevalence and Prognostic Significance of Malnutrition in Patients with Type B Aortic Dissection Undergoing Endovascular Repair
Ting Zhou, Songyuan Luo, Wenhui Lin, et al.
Clinical Interventions in Aging
|
May 7, 2024
Assess the Outcomes of Transcatheter Aortic Valve Replacement in Bicuspid Valve with Mixed Disease versus Predominant Aortic Stenosis
Changjin Wang, Xiaolu Hu, Songyuan Luo, et al.
Asian Journal of Urology
|
February 11, 2021
Sustainable functional urethral reconstruction: Maximizing early continence recovery in robotic-assisted radical prostatectomy
Zepeng Jia, Yifan Chang, Yan Wang, et al.
Journal of Cellular Physiology
|
November 19, 2013
miR-663 induces castration-resistant prostate cancer transformation and predicts clinical recurrence
Li Jiao, Zhen Deng, Chuanliang Xu, et al.
The Journal of Urology
|
October 19, 2010
Testosterone and androgen receptor in human nephrolithiasis
Jin-Yi Li, Tie Zhou, XiaoFeng Gao, et al.
Oncotarget
|
March 5, 2016
Nomograms for predicting Gleason upgrading in a contemporary Chinese cohort receiving radical prostatectomy after extended prostate biopsy: development and internal validation
Biming He, Rui Chen, Xu Gao, et al.
BMC Cancer
|
June 21, 2019
Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms
Shuxiong Zeng, Anwei Liu, Lihe Dai, et al.
BJU International
|
May 27, 2018
Renal function changes after percutaneous nephrolithotomy in patients with renal calculi with a solitary kidney compared to bilateral kidneys
Xiaolei Shi, Yonghan Peng, Ling Li, et al.
BMC Cancer
|
March 22, 2013
Safety and efficacy of everolimus in Chinese patients with metastatic renal cell carcinoma resistant to vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: an open-label phase 1b study
Jun Guo, Yiran Huang, Xu Zhang, et al.
Molecular Cancer Therapeutics
|
December 29, 2012
miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR
Chuanliang Xu, Qinsong Zeng, Weidong Xu, et al.
Page
of 29